• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bacil Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 3688.0
  • ISIN : INE711D01018
42.49 1 (1.41%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    39.82

  • Today’s High

    43.99

  • Open

    42.10

  • Perv Close

    41.90

  • 52W Low

    14.63

  • 52W High

    62.56

Key Indicators

  • P/E(TTM)

    72.02

  • Mar.Cap (₹Cr.)

    25.03

  • Div & Yield %

    0.00

  • Book Value(₹)

    1.79

  • Debt-Equity Ratio

    1.41

  • AGM Date

    28-Mar-2025

  • EPS

    0.59

  • P/E Ratio

    72.02

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    25.03

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.89

  • BV (₹)

    1.80

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -0.16

  • NP Var(%)

    -5.0

  • Div%

    0.0

  • CPS (₹)

    -0.30

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    25.03

  • 52 Week High

    62.56

  • 52 Week Low

    14.63

  • Price BSE

    42.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    25.03

  • P/C Ratio

    -156.70

  • P/E Ratio

    -154.80

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.13 0.11 0.06 0.07 0.14 0.09
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.13 0.11 0.06 0.07 0.14 0.09
EXPENDITURE :
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power & Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 0.10 0.09 0.06 0.05 0.09 0.08
Other Manufacturing Expenses 0.00 0.05 3.76 0.18 0.27 0.18
Selling & Administrative Expenses 0.08 0.08 0.09 0.08 0.08 0.16
Miscellaneous Expenses 0.00 0.05 3.76 0.18 0.27 0.18
Less : Pre-operative Expenses Capitalised :
Total Expenditure 0.19 0.22 3.92 0.31 0.46 0.44
Operating Profit 0.00 0.00 0.00 0.00 0.00 0.01
Interest 0.00 0.00 0.00 0.00 0.00 0.00
Gross Profit -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Depreciation 0.00 0.00 0.00 0.00 0.01 0.01
Profit Before Tax -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Extraordinary Items -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Adjusted Net Profit -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.06 -0.10 -3.86 -0.24 -0.32 -0.34
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.10 -0.17 -6.55 -0.41 -0.54 -0.58
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    10.60%

  • Public Share Holding

    89.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 293,101 4.98 282,101 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 331,230 5.62 330,730 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 624,331 10.60 612,831 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,084,619 18.41 1,036,019 25
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 87,291 1.48 12,891 108
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,080,834 18.35 966,834 19
Individuals holding nominal share capital up to Rs. 1 lakh 2,890,151 49.07 961,951 7,277
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 200 0.00 200 1
Others 122,574 2.08 122,574 23
Sub Total 5,265,669 89.40 3,100,469 7,453
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,890,000 100.00 3,713,300 7,461

Company Background

Bacil Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Bacil Pharma Ltd
  • BSE Code : 3688.0
  • ISIN : INE711D01018

  • Incorporation Year

    1987

  • Registered Office

    G2 & G3 Samarpan Complex
    chakala Andheri East, Mumbai,
    Maharashtra-400099

  • Telephone

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Bhavana Tak

  • Auditor

    Laxmikant Kabra & Co LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

Bacil Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bacil Pharma 42.49 0.13 0.00 72.02 0.00
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92